Drug Pipeline

Neoadjuvant Therapy(SOX Chemotherapy) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-15 NCT07590570 The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in… Active, Not Recruiting
Active Studies by Phase
Phase 2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07103395 A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With… Lung Cancer (NSCLC) Recruiting
NCT06766578 Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX… Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Recruiting
NCT06829797 A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab… Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Recruiting
Not specified
NCT07590570 The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in… Breast Cancer Invasive Active, Not Recruiting
Sponsors Running Neoadjuvant Therapy(SOX Chemotherapy) Trials
Shandong Provincial Hospital (2) Sun Yat-sen University (1) Wenjin Yin (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1)
Get alerts when Neoadjuvant Therapy(SOX Chemotherapy) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free